Effects of HIIT VR Exergame on Attention and Executive Function in Young People With ADHD

Launched by HOSPITAL DE CLINICAS DE PORTO ALEGRE · Oct 7, 2024

Keywords

ClinConnect Summary

This clinical trial is studying whether a virtual reality game called "Move Sapiens," combined with a short workout routine known as High-Intensity Interval Training (HIIT), can help improve attention and thinking skills in young people with Attention-Deficit Hyperactivity Disorder (ADHD). The researchers want to find out if playing this game can also reduce other issues like sleep problems and anxiety. Participants will either play the HIIT VR game or a version of the game without physical exercise, and they will do this five times a week for four weeks.

To be eligible for this trial, young people must be between 12 and 17 years old, have a diagnosis of ADHD, and should not have taken ADHD medication for at least a month before starting the study. Participants will visit the clinic for assessments and tests to see how well the game works. It's important to note that individuals with certain medical conditions or who engage in regular intense physical activity may not be suitable for this study. Overall, this trial aims to learn more about using innovative technology to help manage ADHD symptoms in adolescents.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • participants with diagnosis of ADHD according to DSM-5;
• • age between 12 and 17 years;
• • no prior use of ADHD medication or have not been using ADHD medication for at least one month.
• Exclusion Criteria:
• • participants with conditions and comorbidities that prevent the execution of HIIT in VR, such as severe additional psychiatric and physical conditions and a history of seizures;
• • inattention score below 12 on the SNAP-IV inattention subscale;
• • IQ below 70;
• • recreationally active people who engage in intense, systematic physical activity more than two times a week.
• For the MRI assessment, the following exclusionary criteria are added:
• • participants with non-compatible aneurysm clips, cochlear implants, pacemakers, metal fragments in the body or eyes, or non-removable piercings;
• • internal metal residues that interfere with image acquisition and analysis;
• • severe claustrophobia;
• • respiratory difficulties that prevent cooperation;
• • inability to remain still due to hyperactivity;
• • body weight and size exceeding device limits;
• • excessive involuntary movement;
• • anatomical abnormalities.